Dahal A - Search Results

1

Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.

Parajuli P, Sable R, Shrestha L, Dahal A, Gauthier T, Taneja V, Jois S. Parajuli P, et al. Among authors: dahal a. Chem Biol Drug Des. 2021 Mar;97(3):607-627. doi: 10.1111/cbdd.13797. Epub 2020 Oct 2. Chem Biol Drug Des. 2021. PMID: 32946175 Free PMC article.

2

Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor.

Kaufman NEM, Meng Q, Griffin KE, Singh SS, Dahal A, Zhou Z, Fronczek FR, Mathis JM, Jois SD, Vicente MGH. Kaufman NEM, et al. Among authors: dahal a. J Med Chem. 2019 Apr 11;62(7):3323-3335. doi: 10.1021/acs.jmedchem.8b01746. Epub 2019 Mar 25. J Med Chem. 2019. PMID: 30835998 Free PMC article.

3

Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy.

Singh SS, Dahal A, Shrestha L, Jois SD. Singh SS, et al. Among authors: dahal a. Curr Med Chem. 2020;27(32):5274-5316. doi: 10.2174/0929867326666190222183219. Curr Med Chem. 2020. PMID: 30854949 Review.

4

The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.

Musarrat F, Chouljenko V, Dahal A, Nabi R, Chouljenko T, Jois SD, Kousoulas KG. Musarrat F, et al. Among authors: dahal a. J Med Virol. 2020 Oct;92(10):2087-2095. doi: 10.1002/jmv.25985. Epub 2020 May 17. J Med Virol. 2020. PMID: 32374457 Free PMC article.

5

In vivo studies of a peptidomimetic that targets EGFR dimerization in NSCLC.

Shrestha L, Singh SS, Parajuli P, Dahal A, Mattheolabakis G, Meyer S, Bhattacharjee J, Jois SD. Shrestha L, et al. Among authors: dahal a. J Cancer. 2020 Aug 18;11(20):5982-5999. doi: 10.7150/jca.46320. eCollection 2020. J Cancer. 2020. PMID: 32922539 Free PMC article.

6

Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.

Sonju JJ, Dahal A, Singh SS, Jois SD. Sonju JJ, et al. Among authors: dahal a. J Control Release. 2021 Jan 10;329:624-644. doi: 10.1016/j.jconrel.2020.09.055. Epub 2020 Oct 1. J Control Release. 2021. PMID: 33010333 Free PMC article. Review.

7

A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models.

Singh SS, Mattheolabakis G, Gu X, Withers S, Dahal A, Jois S. Singh SS, et al. Among authors: dahal a. Eur J Med Chem. 2021 Apr 15;216:113312. doi: 10.1016/j.ejmech.2021.113312. Epub 2021 Feb 23. Eur J Med Chem. 2021. PMID: 33667849 Free PMC article.

8

Quinazoline-tethered hydrazone: A versatile scaffold toward dual anti-TB and EGFR inhibition activities in NSCLC.

Emam AM, Dahal A, Singh SS, Tosso RD, Ibrahim SM, El-Sadek M, Jois SD, Enriz RD, Kothayer H. Emam AM, et al. Among authors: dahal a. Arch Pharm (Weinheim). 2021 Dec;354(12):e2100281. doi: 10.1002/ardp.202100281. Epub 2021 Sep 29. Arch Pharm (Weinheim). 2021. PMID: 34585758

9

A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.

Sonju JJ, Dahal A, Singh SS, Gu X, Johnson WD, Muthumula CMR, Meyer SA, Jois SD. Sonju JJ, et al. Among authors: dahal a. Int J Pharm. 2022 Jan 25;612:121364. doi: 10.1016/j.ijpharm.2021.121364. Epub 2021 Dec 9. Int J Pharm. 2022. PMID: 34896567 Free PMC article.

10

Peptides and peptidomimetics as therapeutic agents for Covid-19.

Dahal A, Sonju JJ, Kousoulas KG, Jois SD. Dahal A, et al. Pept Sci (Hoboken). 2022 Jan;114(1):e24245. doi: 10.1002/pep2.24245. Epub 2021 Oct 11. Pept Sci (Hoboken). 2022. PMID: 34901700 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page